GlassScriptPhysician profile
Chelsie Renee Ferrell
NPI 1609204494
$132,095.94
in general payments reported to CMS, 2019-2025
38 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30K · 2022: $29K · 2023: $35K · 2024: $23K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46K · Travel and Lodging: $13K · Consulting Fee: $7,073 · Food and Beverage: $6,939 · Education: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,339.75 |
| Travel and Lodging | $12,930.25 |
| Consulting Fee | $7,073.25 |
| Food and Beverage | $6,938.78 |
| Education | $327.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $122,092.46 | 2021-2025 | Erleada, Akeega, Rybrevant |
| Pfizer INC. | $2,611.70 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,883.06 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $898.55 | 2021-2024 | Erleada, Pipeline |
| Astellas Pharma US INC | $855.39 | 2021-2024 | Xtandi, Veozah, Myrbetriq |
| Procept Biorobotics Corporation | $531.38 | 2024-2025 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $279.08 | 2021-2025 | Prolaris |
| Bioprotect Medical, INC. | $271.71 | 2024-2025 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $264.42 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Teleflex LLC | $223.40 | 2021-2025 | Urolift |
| Astrazeneca Pharmaceuticals LP | $176.78 | 2021-2023 | Lynparza |
| Dendreon Pharmaceuticals LLC | $168.48 | 2021-2024 | Provenge |
| Tempus Ai, INC | $147.13 | 2024-2025 | Xt Cdx |
| Progenics Pharmaceuticals, INC. | $140.52 | 2025 | |
| Coloplast Corp | $133.54 | 2022-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsie Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.